Regulation of aryl hydrocarbon receptor signal transduction by protein tyrosine kinases

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor.
• AhR signaling pathways are crucial in cellular responses to xenobiotics.
• Protein tyrosine kinases (PTKs) play diverse roles in cell signaling.

Purpose of the Study:

• To investigate the role of PTKs in AhR signaling induced by omeprazole and TCDD.
• To elucidate the specific mechanisms of AhR activation by omeprazole versus TCDD.
• To identify key molecular players in omeprazole-mediated AhR signaling.

Main Methods:

• Hepatoma cell lines were used for experiments.
• Inhibition of c-src kinase using specific inhibitors (PP1, PP2) and dominant-negative c-src.
• Treatment with tyrosine kinase inhibitors (AG17, AG879).
• Site-directed mutagenesis of a putative phosphorylation site (Tyr320 to Phe).

Main Results:

• Both omeprazole- and TCDD-induced AhR signaling were attenuated by c-src kinase inhibition.
• Omeprazole-mediated AhR signaling was selectively inhibited by tyrphostins AG17 and AG879.
• Mutation of Tyr320 to Phe abolished omeprazole-dependent AhR activation, suggesting it's a phosphorylation site.
• TCDD-dependent AhR signaling was unaffected by tyrphostins and the Tyr320 mutation.

Conclusions:

• AhR function is modulated by c-src kinase activity.
• Omeprazole activates AhR via a ligand-independent pathway involving PTKs, differing from high-affinity ligands like TCDD.
• Specific tyrosine residues are involved in omeprazole-induced AhR activation.